Moderna seeks FDA authorization for 4th dose of Covid shot

Moderna seeks FDA authorization for 4th dose of Covid shot


Illustration of a vial of Moderna vaccine for coronavirus treatment.

Marcos Del Mazo | Lightrocket | Getty Images

Drugmaker Moderna asked the Food and Drug Administration on Thursday to authorize a fourth shot of its Covid-19 vaccine as a booster dose for all adults.

The request is broader than rival pharmaceutical company Pfizer’s request earlier this week for the regulator to approve a booster shot for all seniors.

In a press release, the company said its request for approval for all adults was made “to provide flexibility” to the Centers for Disease Control and Prevention and medical providers to determine the “appropriate use” of a second booster dose of the mRNA vaccine, “including for those at higher risk of COVID-19 due to age or comorbidities.”

U.S. officials have been laying the groundwork to deliver additional booster doses to shore up the vaccines’ protection against serious disease and death from Covid-19. The White House has been sounding the alarm that it needs Congress to “urgently” approve more funding for the federal government to secure more doses of the Covid-19 vaccines, either for additional booster shots or variant-specific immunizations.

U.S. health officials currently recommend a primary series of two doses of the Moderna vaccine and a booster dose months later.

CNBC Health & Science

Read CNBC’s latest global coverage of the Covid pandemic:

Moderna said its request for an additional dose was based on “recently published data generated in the United States and Israel following the emergence of Omicron.”

On Tuesday, Pfizer and its partner BioNTech asked U.S. regulators to authorize an additional booster dose of their Covid-19 vaccine for seniors, saying data from Israel suggests older adults would benefit.



Source

China’s industrial profits plunge 9.1%, steepest fall in seven months
World

China’s industrial profits plunge 9.1%, steepest fall in seven months

A worker checks a finished vehicle on the production line for electric vehicle maker Zeekr at its factory on May 29, 2025 in Ningbo, China. Kevin Frayer | Getty Images News | Getty Images China’s industrial profits plunged 9.1% in May from a year earlier, in the latest sign that Beijing’s stimulus efforts are falling […]

Read More
CNBC Daily Open: Wall Street is chill, cheeky and cruising
World

CNBC Daily Open: Wall Street is chill, cheeky and cruising

Jerry O’Callaghan, former chairman of JBS SA, center, speaks with a trader on the floor of the New York Stock Exchange in New York, U.S., on Wednesday, June 25, 2025. Michael Nagle | Bloomberg | Getty Images I am Spriha Srivastava, CNBC International’s executive editor for digital, and I am writing to you today from […]

Read More
Asia-Pacific markets track Wall Street gains after White House downplays tariff deadline
World

Asia-Pacific markets track Wall Street gains after White House downplays tariff deadline

Aerial view of Osaka Skyline Nikada | E+ | Getty Images Asia-Pacific markets mostly rose Friday, tracking Wall Street’s gains after White House spokesperson Karoline Leavitt downplayed the impending start of the tariff deals, which have weighed on investor sentiment. July 8 is when the so-called liberation day tariffs are set to take effect after […]

Read More